Arovella Therapeutics Limited announced a private placement that it will issue 719,424 common shares to receive funding on July 4, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.165 AUD | +6.45% |
|
+17.86% | +43.48% |
07-04 | Arovella Therapeutics Limited announced a financing transaction | CI |
06-13 | Arovella Therapeutics, Teva Pharmaceuticals End ZolpiMist License Agreement | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+43.48% | 110M | |
+25.83% | 47.96B | |
+0.69% | 42.45B | |
+44.47% | 41.47B | |
+30.52% | 31.6B | |
+22.30% | 28.63B | |
-6.35% | 28.03B | |
+49.25% | 14.56B | |
+49.18% | 14.14B | |
+3.45% | 12.58B |
- Stock Market
- Equities
- ALA Stock
- News Arovella Therapeutics Limited
- Arovella Therapeutics Limited announced a financing transaction